SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-16
👔
Cadrenal Therapeutics, Inc.
@CVKD_InsiderForm 4 Filing: Pham Quang X Sells $70,351.96 of $CVKD
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Cadrenal Therapeutics, Inc.
Ticker: $CVKD
Transaction Value
$70,351.96
Price/Share: $3.88
transaction date
2026-06-12
Shares: 18,124
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pham Quang X, holds the title of Chairman, CEO and Interim CFO at Cadrenal Therapeutics, Inc..
On 2026-06-12, the insider transacted 18,124 shares.The shares were transacted at a weighted average price of $3.88 per share, resulting in a total market-relevant value of $70,351.96.
Executive Summary Summary
Pham Quang X (Chairman, CEO and Interim CFO) sold $70K of $CVKD
Post-Transaction Position: 136,381 shares
SEC Accession No: 0001213900-26-068981 (CIK: 1405290)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.